Preservative Free Eye drops solution in single-dose container for the reduction of elevated intraocular pressure in patients with open angle glaucoma and ocular hypertension.
The first and only preservative-free latanoprost, Monopost removes the risk of ocular surface problems that have been reported to be caused by long-term preservative containing eye drops.
Monopost has been shown to provide non-inferior IntraOcular Pressure (IOP) control compared to Xalatan with statistically significantly lower hyperaemia and symptoms on instillation.1
Studies where patients have been switched from preserved to preservative-free latanoprost (Monopost) have demonstrated reductions in the frequency and severity of hyperaemia and other symptoms.2
1 Rouland, J.F. et al. Br J Ophthalmol. 2013;97(2):196-200
2 Misiuk-Hojło, M. et al. EVER 2014 congress. Poster #T018